Products & Services
Newert to Launch On-Device AI Biosignal Equipment to Advance Digital Healthcare Research in Everyday Environments
Newert (CEO Lee Jung-nyeon), which provides full-cycle biosignal solution services, announced that it will launch "EmoConnect PPG&Motion," an On-Device AI-based biosignal measurement device and software.
Recently KC-certified, "EmoConnect PPG&Motion" is a smart-band wearable that can monitor biosignals and movement at the same time. It applies AI technology to keep raw-data collection stable where a user's activity — walking, driving, and so on — would otherwise distort the signal, and delivers equipment and technology specialized for companies and research institutes that need biosignal-based research and technology development in digital healthcare.
Aiming to become Korea's No.1 biosignal solution specialist, Newert currently offers everything from composite biosignal measurement module development to biosignal SW development, analysis, and consulting services. Drawing on the pain points of existing biosignal development environments — accuracy degraded by noise, data left unusable when the responsible staff member is away — the company will launch its biosignal measurement device and software (EmoConnect PPG&Motion) together with a biosignal data platform (Biosignal Data-hub) so that standardized data can be managed properly.
Newert presented at Korea's HCI conference in 2024 on "A Case Study of Digital Transformation (DX) of Biosignal Data for Data Assetization," and currently holds approximately 90TB of biosignal data.
Newert CEO Lee Jung-nyeon said, "We hold our own biosignal measurement devices and software along with core noise-filtering technology," adding, "Through biosignal measurement technology that stays accurate and reliable even in varied everyday environments, we plan to deliver innovative solutions in digital healthcare and lead the field of digital medical and health support devices and technologies."
[Startup Daily = Reporter Bella] bella@startupdaily.com
Related news
Newert Achieves Its First Export of EmoConnect PPG&Motion to China
Newert has achieved its first export to the Chinese market with EmoConnect PPG&Motion, the biosignal measurement device for research and development that the company designed in-house. The export was made under a contract with the Chinese corporation "HEBEI KANGHU INTELLIGENT SENSING TECHNOLOGY," marking an important milestone in Newert's move into global markets. Starting with China, the company is sequentially preparing the international certifications required to enter the United States, Europe, and other regions.
Newert, Supplier of Biosignal Raw Data and SDKs, Sells Out Its Initial Run of 'EmoConnect PPG&Motion'
Newert, which supplies solutions for research and development in the biosignal field, announced on the 8th that the initial production run of 'EmoConnect PPG&Motion' — the wristband-type biosignal measurement device it recently released — has sold out. A Newert representative said that while biosignal measurement devices on the market often provide raw data and SDKs only in limited form, or not at all, 'EmoConnect PPG&Motion' removes those constraints and has drawn strong interest from researchers and developers.
Newert Launches Wearable Biosignal Measurement Equipment and Software for R&D, Including Raw Data Access
Few companies in Korea develop and supply solutions for research and development in the biosignal field. Equipment on the market has also tended to restrict movement with wired sensors or to limit the data it provides, making applied R&D and business expansion difficult. Newert (CEO Lee Jung-nyeon) announced on the 16th that it has launched EmoConnect PPG&Motion, a wireless wearable biosignal measurement device supplied together with the raw data it collects and an SDK for commercialization.